WIN 55,212-2 mesylate (a highly potent non-selective cannabinoid CB1 and CB2 receptor agonist) elevates the threshold for maximal electroshock-induced seizures in mice

• Autorzy: Luszczki J.J. , Misiuta-Krzesinska M. , Wlaz A. , Zwolinski J. , Cioczek J. D. , Zolkowska D.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Journal of Pre-Clinical and Clinical Research
• Rocznik: 2009
• Tom: 03
• Numer: 2
• Opis fizyczny: p.110-113,fig.,ref.

Twórcy

autor

Luszczki J.J.

• Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland
• Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland

autor

Misiuta-Krzesinska M.

• Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland

autor

Wlaz A.

• Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland

autor

Zwolinski J.

• Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland

autor

Cioczek J. D.

• Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland
• Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland

autor

Zolkowska D.

• Department of Neurology, UC Davis School of Medicine,Sacramento, USA